Last Posted: Apr 03, 2020
- A Need for Better Understanding Is the Major Determinant for Public Perceptions of Human Gene Editing.
McCaughey Tristan et al. Human gene therapy 2019 30(1) 36-43 - Gene therapy for hearing loss.
Omichi Ryotaro et al. Human molecular genetics 2019 28(R1) R65-R79 - Has retinal gene therapy come of age? From bench to bedside and back to bench.
Trapani Ivana et al. Human molecular genetics 2019 28(R1) R108-R118 - Sport and exercise genomics: the FIMS 2019 consensus statement update.
Tanisawa Kumpei et al. British journal of sports medicine 2020 Mar - [Clinical practice guidelines for beta-thalassemia].
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Mar 37(3) 243-251 - Genetic testing for inherited ocular conditions in a developing country.
Zanolli Mario et al. Ophthalmic genetics 2020 Mar 1-5 - The special considerations of gene therapy for mitochondrial diseases.
Slone Jesse et al. NPJ genomic medicine 2020 57 - Strategies for fighting mitochondrial diseases.
Viscomi Carlo et al. Journal of internal medicine 2020 Feb - Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
Kondkar Altaf A et al. Experimental eye research 2019 189107834 - The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis.
Hlávka Jakub P et al. Applied health economics and health policy 2020 Feb
No hay comentarios:
Publicar un comentario